Updated Monday, September 25, 2017
JCIM & JIM
Open Access
THIS ARTICLE
-  Abstract
-  Full text
-  Download PDF file
-  Send to a friend
-  Related articles in JCIM & JIM
-  Cited in JCIM & JIM
-  Reader's comments
-  Send a comment
 Language Polishing
Original Experimental Research
Journal of Chinese Integrative Medicine: Volume 10, 2012   Issue 4
Chinese herbal decoction Shiquan Dabu Tang inhibits tumor growth and angiogenesis of metastasis after primary tumor surgical removal in mice
1. Gang Guo (Department of Oncology, Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China )
2. Jian-hua Xu (Department of Oncology, Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China E-mail: E-mail: xujianhua50@yahoo.com.cn)
3. Jian-hong Han (Department of Oncology, Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China )
4. Fang Liang (Department of Oncology, Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China )
5. Yong Zhang (Department of Oncology, Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China )
6. Qiang Zhang (Department of Oncology, Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China )
7. Jue Sun (Department of Oncology, Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China )
8. Zhong-ze Fan (Department of Oncology, Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China )
OBJECTIVE: This study aimed to investigate the effects of Shiquan Dabu Tang (SDT) on growth and angiogenesis of subcutaneously implanted tumors, hepatic metastases, and incision-implanted tumors after surgical removal of primary colon tumor in mice.
METHODS: Three experimental models were built after surgical removal of primary colon tumor and the mice were randomly divided into three groups: primary tumor resection (TR) group, primary tumor-preserved (TP) group and SDT group. After resection of the primary tumor and SDT treatment for 10 d, levels of vascular endothelial growth factor (VEGF), angiostatin (AS) and endostatin (ES) were examined by enzyme-linked immunosorbent assay (ELISA); microvascular density (MVD) and cell proliferation of metastasis were detected by streptavidin-peroxidase immunohistochemical staining; tumor cell apoptosis was detected by terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling (TUNEL) assay.
RESULTS: In the subcutaneously implanted tumor model, the average volume of metastases of the SDT group was significantly lower than that of the TR group (P<0.01); the incidence rate of metastases was 50%. In the hepatic metastases model, the average number of hepatic metastases nodules of the SDT group was significantly lower than that of the TR group (P<0.01); the incidence rate of metastases was 40%. In the incision-implanted tumor model, the average volume of metastases of the SDT group was significantly lower than that of the TR group; the incidence rate of metastases was 30%. MVD was significantly inhibited by SDT and Ki67 expression of the SDT group was significantly lower than that of the TR group (P<0.01). TUNEL apoptotic index of tumor of the SDT group was higher than that of the TR group (P<0.01). ELISA showed that the serum VEGF level was significantly decreased and the serum ES level was significantly increased in the SDT group compared with those in the TR group (P<0.01).
CONCLUSION: Resection of primary tumor in mice causes imbalance of VEGF, AS and ES, thus promoting angiogenesis and metastasis of tumors. SDT can inhibit growth, angiogenesis and cell proliferation of the metastatic tumor and promote cell apoptosis after surgical removal of the primary tumors.

Received August 21, 2011; accepted September 15, 2011; published online April 15, 2012.
Full-text LinkOut at PubMed. Journal title in PubMed: Zhong Xi Yi Jie He Xue Bao.

Correspondence: Jian-hua Xu, MD, Professor; Tel: 021-62540311; E-mail: xujianhua50@yahoo.com.cn

Full text of this article is in Chinese

  
References
1. Tsoulfas G, Pramateftakis MG, Kanellos I. Surgical treatment of hepatic metastases from colorectal cancer[J]. World J Gastrointest Oncol, 2011, 3(1) : 1-9.
    
2. van der Bij GJ, Oosterling SJ, Beelen RH, Meijer S, Coffey JC, van Egmond M. The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer[J]. Ann Surg, 2009, 249(5) : 727-734.
    
3. Zee-Cheng RK. Shi-quan-da-bu-tang (ten significant tonic decoction), SQT. A potent Chinese biological response modifier in cancer immunotherapy, potentiation and detoxification of anticancer drugs[J]. Methods Find Exp Clin Pharmacol, 1992, 14(9) : 725-736.
  
4. Ohnishi Y, Fujii H, Hayakawa Y, Sakukawa R, Yamaura T, Sakamoto T, Tsukada K, Fujimaki M, Nunome S, Komatsu Y, Saiki I. Oral administration of a Kampo (Japanese herbal) medicine Juzen-taiho-to inhibits liver metastasis of colon 26-L5 carcinoma cells[J]. Jpn J Cancer Res, 1998, 89(2) : 206-213.
    
5. Matsuo M, Tani T, Saiki I. Organ selectivity of Juzen-taiho-to and Ninjin-yoei-to in the expression of anti-metastatic efficacy[J]. J Trad Med, 2002, 19(3) : 93-97.
[sciencelinks]  
6. Kamiyama H, Takano S, Ishikawa E, Tsuboi K, Matsumura A. Anti-angiogenic and immunomodulatory effect of the herbal medicine “Juzen-taiho-to” on malignant glioma[J]. Biol Pharm Bull, 2005, 8(11) : 2111-2116.
    
7. Halder J, Kamat AA, Landen CN Jr, Han LY, Lutgendorf SK, Lin YG, Merritt WM, Jennings NB, Chavez-Reyes A, Coleman RL, Gershenson DM, Schmandt R, Cole SW, Lopez-Berestein G, Sood AK. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy[J]. Clin Cancer Res, 2006, 12(16) : 4916-4924.
    
8. Hwang JY, Mangala LS, Fok JY, Lin YG, Merritt WM, Spannuth WA, Nick AM, Fiterman DJ, Vivas-Mejia PE, Deavers MT, Coleman RL, Lopez-Berestein G, Mehta K, Sood AK. Clinical and biological significance of tissue transglutaminase in ovarian carcinoma[J]. Cancer Res, 2008, 68(14) : 5849-5858.
    
9. Fisher B, Gunduz N, Saffer EA. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases[J]. Cancer Res, 1983, 43(4) : 1488-1492.
  
10. Iwanuma Y, Chen FA, Egilmez NK, Takita H, Bankert RB. Antitumor immune response of human peripheral blood lymphocytes coengrafted with tumor into severe combined immunodeficient mice[J]. Cancer Res, 1997, 57(14) : 2937-2942.
  
11. Hofer SO, Shrayer D, Reichner JS, Hoekstra HJ, Wanebo HJ. Wound-induced tumor progression: a probable role in recurrence after tumor resection[J]. Arch Surg, 1998, 133(4) : 383-389.
    
12. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors[J]. Breast Cancer Res Treat, 1995, 36(2) : 169-180.
    
13. Kontogeorgos G. Classification and pathology of pituitary tumors[J]. Endocrine, 2005, 28(1) : 27-35.
    
14. McLennan G, Cressman EN, Xu Y, Zhang D, Jagtap MR, Jayaram HN. The effect of benzamide riboside on the VX2 model of liver cancer in rabbits[J]. J Vasc Interv Radiol, 2005, 16(11) : 1499-1504.
    
15. Demicheli R, Retsky MW, Hrushesky WJ, Baum M, Gukas ID. The effects of surgery on tumor growth: a century of investigations[J]. Ann Oncol, 2008, 19(11) : 1821-1828.
    
16. Retsky M, Demicheli R, Hrushesky W, Baum M, Gukas I. Surgery triggers outgrowth of latent distant disease in breast cancer: an inconvenient truth? Cancers. 2010; 2(2): 305-337.
[DOAJ]    
17. Matsuda T, Maekawa K, Asano K, Hisamitsu T. Suppressive effect of Juzen-Taiho-To on lung metastasis of B16 melanoma cells in vivo. Evid Based Complement Alternat Med. 2009 Jan 8. [Epub ahead of print]
  
18. Moserle L, Amadori A, Indraccolo S. The angiogenic switch: implications in the regulation of tumor dormancy[J]. Curr Mol Med, 2009, 9(8) : 935-941.
    
19. Zhao T, Xia WH, Zheng MQ, Lu CQ, Han X, Sun YJ. Surgical excision promotes tumor growth and metastasis by promoting expression of MMP-9 and VEGF in a breast cancer model[J]. Exp Oncol, 2008, 30(1) : 60-64.
  
20. Tolentino MJ. Current molecular understanding and future treatment strategies for pathologic ocular neovascularization[J]. Curr Mol Med, 2009, 9(8) : 973-981.
    
21. Nieves BJ, D’Amore PA, Bryan BA. The function of vascular endothelial growth factor[J]. Biofactors, 2009, 35(4) : 332-337.
    
22. Ribatti D. Endogenous inhibitors of angiogenesis: a historical review[J]. Leuk Res, 2009, 33(5) : 638-644.
    
23. Karamouzis MV, Moschos SJ. The use of endostatin in the treatment of solid tumors[J]. Expert Opin Biol Ther, 2009, 9(5) : 641-648.
    
24. Hanahan D, Christofori G, Naik P, Arbeit J. Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models. Eur J Cancer. 1996; 32A(14): 2386-2393.
    
25. Distler O, Neidhart M, Gay RE, Gay S. The molecular control of angiogenesis[J]. Int Rev Immunol, 2002, 21(1) : 33-49.
    
26. O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth[J]. Cell, 1997, 88(2) : 277-285.
    
27. O’Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma[J]. Cell, 1994, 79(2) : 315-328.
    
28. Justinger C, Schlüter C, Oliviera-Frick V, Kopp B, Rubie C, Schilling MK. Increased growth factor expression after hepatic and pancreatic resection[J]. Oncol Rep, 2008, 20(6) : 1527-1531.
  
29. Peeters CF, de Geus LF, Westphal JR, de Waal RM, Ruiter DJ, Wobbes T, Oyen WJ, Ruers TJ. Decrease in circulating anti-angiogenic factors (angiostatin and endostatin) after surgical removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases[J]. Surgery, 2005, 137(2) : 246-249.
    
  
Reader's comments
1. christian louboutin cheap cheap christian louboutin shoes canada http://christianlouboutincanadaoutlet.blogspot.com/ (2016-1-28 0:00:00)
2. louboutin heels christian louboutin shoes sale http://christianlouboutincanadaoutlet.blogspot.com/ (2016-2-22 0:00:00)
3. christian louboutin womens wedges christian louboutin canada sale http://canadachristianlouboutin.blogspot.com/ (2016-2-23 0:00:00)

Send a comment

 Home | Current Issue | Past Issues | SearchRSS
Copyright © 2013-2018 by JIM Editorial Office. All rights reserved. ISSN 2095-4964; CN 31-2083/R. 沪ICP备110264号